Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 97 followers
Latest posts
Last updated 10 days ago
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Arthritis, Rheumatoid, Date of authorisation: 21/03/2017, Date of refusal: 25/04/2013, Revision: 3, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Arthritis, Rheumatoid, Date...
Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Hemophilia A, Date of authorisation: 22/11/2018, Revision: 2, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Hemophilia...
Human medicines European public assessment report (EPAR): Juluca, dolutegravir / rilpivirine, HIV Infections, Date of authorisation: 16/05/2018, Revision: 5, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Juluca, dolutegravir / rilpivirine, HIV...
Human medicines European public assessment report (EPAR): VeraSeal, human fibrinogen / human thrombin, Hemostasis, Surgical, Date of authorisation: 10/11/2017, Revision: 3, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): VeraSeal, human fibrinogen / human...
Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Carcinoma, Squamous Cell, Date of authorisation: 28/06/2019, Revision: 4, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Carcinoma, Squamous Cell...
Human medicines European public assessment report (EPAR): Pemetrexed Hospira, pemetrexed, Carcinoma, Non-Small-Cell Lung,Mesothelioma, Date of authorisation: 19/11/2015, Revision: 10, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Pemetrexed Hospira, pemetrexed, Carcinoma, Non-Small-Cell...
Human medicines European public assessment report (EPAR): Mysimba, naltrexone / bupropion, Obesity,Overweight, Date of authorisation: 26/03/2015, Revision: 16, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Mysimba, naltrexone / bupropion, Obesity,Overweight...
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 13/01/2020, Revision: 3, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Multiple Sclerosis, Relapsing-Remitting...
Human medicines European public assessment report (EPAR): Fortacin, lidocaine / prilocaine, Sexual Dysfunction, Physiological, Date of authorisation: 15/11/2013, Revision: 9, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Fortacin, lidocaine / prilocaine, Sexual...
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Carcinoma, Transitional Cell,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 20/09/2017, Revision: 11, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Carcinoma, Transitional Cell,Carcinoma...
Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid, Fractures, Bone,Cancer, Date of authorisation: 16/08/2012, Revision: 13, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid...
Human medicines European public assessment report (EPAR): Levemir, insulin detemir, Diabetes Mellitus, Date of authorisation: 01/06/2004, Revision: 28, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Levemir, insulin detemir, Diabetes Mellitus...